APAnand Rathi has buy call on with a target price of Rs 5250. The current market price of Pfizer is Rs 4588.5. Time period given by analyst is 1 month when Pfizer's price can reach defined target. Anand Rathi recommended to keep stop loss at Rs 4250.
Pfizer, incorporated in the year 1950, is a Large Cap company (having a market cap of Rs 20966.41 Crore) operating in Pharmaceuticals sector.
Financials
For the quarter ended 30-09-2022, the company has reported a Standalone Total Income of Rs 661.71 Crore, up 8.31 % from last quarter Total Income of Rs 610.92 Crore and up 1.60 % from last year same quarter Total Income of Rs 651.29 Crore. Company has reported net profit after tax of Rs 311.07 Crore in latest quarter.
The company’s top management includes Mr.S Sridhar, Mr.Milind Patil, Mr.Samir Kazi, Mr.Sunil Lalbhai, Mr.Pradip Shah, Mr.Uday Khanna, Ms.Meena Ganesh. Company has Walker Chandiok & Co. LLP as its auditors. As on 30-09-2022, the company has a total of 5 Crore shares outstanding.
Investment Rationale
Pfizer has been under pressure since quiet some time but at this juncture its trading near its crucial weekly support. Previously the stock turned from this level and there was seen a rally towards Rs 6100. Hence, the brokerage advises traders to go long in the stock with a stop loss of 4250.
Promoter/FII Holdings
Promoters held 63.92 per cent stake in the company as of 30-Sep-2022, while FIIs owned 9.43 per cent, DIIs 14.86 per cent.
Pfizer, incorporated in the year 1950, is a Large Cap company (having a market cap of Rs 20966.41 Crore) operating in Pharmaceuticals sector.
Financials
For the quarter ended 30-09-2022, the company has reported a Standalone Total Income of Rs 661.71 Crore, up 8.31 % from last quarter Total Income of Rs 610.92 Crore and up 1.60 % from last year same quarter Total Income of Rs 651.29 Crore. Company has reported net profit after tax of Rs 311.07 Crore in latest quarter.
The company’s top management includes Mr.S Sridhar, Mr.Milind Patil, Mr.Samir Kazi, Mr.Sunil Lalbhai, Mr.Pradip Shah, Mr.Uday Khanna, Ms.Meena Ganesh. Company has Walker Chandiok & Co. LLP as its auditors. As on 30-09-2022, the company has a total of 5 Crore shares outstanding.
Investment Rationale
Pfizer has been under pressure since quiet some time but at this juncture its trading near its crucial weekly support. Previously the stock turned from this level and there was seen a rally towards Rs 6100. Hence, the brokerage advises traders to go long in the stock with a stop loss of 4250.
Promoter/FII Holdings
Promoters held 63.92 per cent stake in the company as of 30-Sep-2022, while FIIs owned 9.43 per cent, DIIs 14.86 per cent.
(Disclaimer: Recommendations given in this section or any reports attached herein are authored by an external party. Views expressed are that of the respective authors/entities. These do not represent the views of Economic Times (ET). ET does not guarantee, vouch for, endorse any of its contents and hereby disclaims all warranties, express or implied, relating to the same. Please consult your financial adviser and seek independent advice.
Read More News on
(What's moving Sensex and Nifty Track latest market news, stock tips and expert advice on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds.)
...moreDownload The Economic Times News App to get Daily Market Updates & Live Business News.